Overall incidence of adverse effects of Losartan is comparable to placebo in clinical studies. The most common adverse events occurring with Losartan at a rate of >1% above placebo was upper respiratory infection (7.9% vs 6.9%), dizziness (3.5% vs 2.1%) and leg pain (1.0% vs 0.0%).